MC2273A1 - Comprimes et granules contenant de la mesna comme substance active - Google Patents

Comprimes et granules contenant de la mesna comme substance active

Info

Publication number
MC2273A1
MC2273A1 MC912205A MC2205A MC2273A1 MC 2273 A1 MC2273 A1 MC 2273A1 MC 912205 A MC912205 A MC 912205A MC 2205 A MC2205 A MC 2205A MC 2273 A1 MC2273 A1 MC 2273A1
Authority
MC
Monaco
Prior art keywords
weight
parts
tablets
mesna
active substance
Prior art date
Application number
MC912205A
Other languages
English (en)
French (fr)
Inventor
Dieter Sauerbier Mm
Engel Juergen
Milsmann Eckart
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of MC2273A1 publication Critical patent/MC2273A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
MC912205A 1990-07-16 1991-07-11 Comprimes et granules contenant de la mesna comme substance active MC2273A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022525 1990-07-16
SG142394A SG142394G (en) 1990-07-16 1994-10-03 Tablet and granulate containing mesna as active agent

Publications (1)

Publication Number Publication Date
MC2273A1 true MC2273A1 (fr) 1993-06-23

Family

ID=25895027

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912205A MC2273A1 (fr) 1990-07-16 1991-07-11 Comprimes et granules contenant de la mesna comme substance active

Country Status (31)

Country Link
US (1) US5262169A (ko)
EP (1) EP0468245B1 (ko)
JP (1) JP3068894B2 (ko)
KR (1) KR100189666B1 (ko)
CN (1) CN1072484C (ko)
AT (1) ATE104548T1 (ko)
AU (1) AU638586B2 (ko)
BG (2) BG60851B1 (ko)
CA (1) CA2047027C (ko)
DE (2) DE4122167A1 (ko)
DK (1) DK0468245T3 (ko)
EG (1) EG20019A (ko)
ES (1) ES2063412T3 (ko)
FI (1) FI97949C (ko)
HK (1) HK129894A (ko)
HR (1) HRP920889B1 (ko)
HU (1) HU206630B (ko)
IE (1) IE65373B1 (ko)
IL (1) IL98836A (ko)
LT (1) LT3527B (ko)
LV (1) LV10040B (ko)
MC (1) MC2273A1 (ko)
MX (1) MX174407B (ko)
NO (1) NO178362C (ko)
NZ (1) NZ238941A (ko)
PT (1) PT98325B (ko)
RO (1) RO113713B1 (ko)
RU (1) RU2070040C1 (ko)
SG (1) SG142394G (ko)
SI (1) SI9111226A (ko)
ZA (1) ZA915515B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0560092B1 (de) * 1992-03-11 1997-12-03 ASTA Medica Aktiengesellschaft Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
EP0955040A1 (de) 1998-04-27 1999-11-10 ASTA Medica Aktiengesellschaft Arzneiform zur oralen Applikation von Mesna
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6075053A (en) * 1999-02-09 2000-06-13 Bionumerik Pharmaceuticals, Inc. Method of reducing or reversing neuropathy
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1307786C (en) * 1984-12-14 1992-09-22 Keiichi Yokoyama Quinazoline derivatives and antihypertensive preparations containing same as effective components
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.

Also Published As

Publication number Publication date
NO912771D0 (no) 1991-07-15
NO912771L (no) 1992-01-17
RO113713B1 (ro) 1998-10-30
CA2047027A1 (en) 1992-01-17
ATE104548T1 (de) 1994-05-15
IL98836A (en) 1994-11-28
FI913409A0 (fi) 1991-07-15
HU206630B (en) 1992-12-28
IE65373B1 (en) 1995-10-18
FI97949B (fi) 1996-12-13
LT3527B (en) 1995-11-27
FI97949C (fi) 1997-03-25
DE4122167A1 (de) 1992-01-23
PT98325A (pt) 1992-05-29
IE912463A1 (en) 1992-01-29
US5262169A (en) 1993-11-16
HUT59317A (en) 1992-05-28
LV10040A (lv) 1994-05-10
IL98836A0 (en) 1992-07-15
RU2070040C1 (ru) 1996-12-10
LTIP920A (en) 1995-03-27
CN1058337A (zh) 1992-02-05
JP3068894B2 (ja) 2000-07-24
HU912374D0 (en) 1991-12-30
SG142394G (en) 1995-01-13
KR920002154A (ko) 1992-02-28
AU8044591A (en) 1992-01-16
BG60901B1 (bg) 1996-06-28
HK129894A (en) 1994-12-02
NO178362B (no) 1995-12-04
BG60851B1 (bg) 1996-05-31
PT98325B (pt) 1999-01-29
NZ238941A (en) 1993-03-26
KR100189666B1 (ko) 1999-06-01
CA2047027C (en) 1996-09-17
HRP920889A2 (en) 1996-04-30
HRP920889B1 (en) 1998-02-28
ZA915515B (en) 1992-04-29
CN1072484C (zh) 2001-10-10
EP0468245A1 (de) 1992-01-29
EP0468245B1 (de) 1994-04-20
SI9111226A (en) 1995-04-30
DE59101431D1 (de) 1994-05-26
ES2063412T3 (es) 1995-01-01
AU638586B2 (en) 1993-07-01
FI913409A (fi) 1992-01-17
NO178362C (no) 1996-03-13
DK0468245T3 (da) 1994-05-16
JPH04230319A (ja) 1992-08-19
EG20019A (en) 1997-01-30
MX174407B (es) 1994-05-13
LV10040B (en) 1995-06-20

Similar Documents

Publication Publication Date Title
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
GT198303076A (es) Formulaciones de pastillas de accion prolongada con disolucion paulatina.
UA29406C2 (uk) Складні ефіри трициклічних аміноспиртів
MC2273A1 (fr) Comprimes et granules contenant de la mesna comme substance active
KR900700021A (ko) 냉동 분쇄 어육 첨가용 품질 개량제 및 이것을 사용한 냉동 분쇄어육의 제조방법
PE68899A1 (es) Composicion que contiene paracetamol
JPS6434909A (en) Cosmetic
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
GB2021409A (en) Pharmaceutical composition
YU122691A (sh) Tablete i granulat koji kao aktivnu materiju sadrže natrijum-2-merkapto-etansulfonat
SE8704240L (sv) Analgetiska preparat
EA199800573A1 (ru) Таблетки с высоким содержанием фамцикловира
FR2678144B1 (fr) Compositions sous forme de pellets contenant des principes actifs degradables par la chaleur et la pression.
KR920000316A (ko) 젬피브로질 제제
KR920700658A (ko) 칼륨 보충을 위한 약학 조성물
KR930007451A (ko) 우리딘을 유효성분으로 함유하는 관절염 치료제
RU94015620A (ru) Ветеринарный препарат "трикаптол" для лечения гастроэнтеритов молодняка сельскохозяйственных животных
TH13475A (th) สูตรผสมทางเภสัชกรรม
KR890000647A (ko) 무좀 방지용 비누의 제조방법
TH14574A (th) สารผสมทางเภสัชกรรม
KR840008293A (ko) 냉장고 탈취용 탈취제의 제법
KR850008097A (ko) 경구투여를 위한 고형의 서방성 제제방법 및 캅셀 제제방법
TH14737A (th) สารผสมทางเภสัชศาสตร์ที่คงตัวของอนุพันธ์ฟิวแมจิลลอล